Clinical Trial Update: Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing a nifedipine/candesartan fixed-dose combination with a loose combination of nifedipine GITS and candesartan under fasting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Candesartan (candesartan)
• Nifedipine GITS (nifedipine)
• Nifedipine/Candesartan Fixed-Dose Combination (Nifedipine and Candesartan)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Essential | Phase 1 | Status: COMPLETED